ICCM'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Icecure Medical Ltd ICCM'ün son çeyrekteki geliri nasıl performans gösterdi?
Icecure Medical Ltd'in gelir tahmini nedir?
Icecure Medical Ltd'in kazanç kalite puanı nedir?
Icecure Medical Ltd kazançlarını ne zaman rapor eder?
Icecure Medical Ltd'in beklenen kazançları nelerdir?
Icecure Medical Ltd kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.5512
Açılış fiyatı
$0.564
Günün Aralığı
$0.564 - $0.6
52 haftalık aralık
$0.54 - $1.66
İşlem hacmi
132.5K
Ort.Hacim
342.6K
EPS (TTM)
-0.26
Dividend yield
--
Piyasa Değeri
$40.6M
ICCM nedir?
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. The firm operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.